Table 3.
Main clinical outcomes of patients with acute decompensate aortic stenosis receiving transcatheter aortic valve replacement
| First author, year | n | Device success, n (%) | Follow-up | Stroke, n (%) | Major bleeding, n (%) | Vascular complications, n (%) | Acute kidney injury, n (%) | Moderate/severe PVL, n (%) | Mortality at longest follow-up, n (%) |
|---|---|---|---|---|---|---|---|---|---|
| Landes, 2016 [16] | 27 | 23 (85.2) | 30-day | 1 (3.7) | 1 (3.7) | 5 (18.5) | 4 (14.8) | 2 (9.5) | 1 (3.7) |
| Frerker, 2016 [15] | 27 | 24 (88.9) | 1-year | 1 (3.7) | 1 (3.7) | 9 (33.3) | 8 (29.6) | 1 (3.7) | 11 (40.7) |
| Kolte, 2018 [12] | 3952 | 3659 (92.6) | 1-year | 91 (2.3) | 324 (8.3) | 39 (1.0) | 323 (8.2) | 159 (4.0) | 1185 (29) |
| Abdelaziz, 2018 [8] | 76 | 2-year | 2 (2.6) | 7 (9.2) | 4 (5.3) | 14 (18.4) | |||
| Bongiovanni, 2018 [14] | 23 | 30-day | 2 (8.7) | 1 (4.3) | 5 (21.7) | 3 (13) | 1 (4.3) | 5 (23.8) | |
| Elbadawi, 2020 [11] | 10,089 | In-hospital | 274 (2.7) | 3628 (36) | 214 (2.1) | 2827 (28) | 565 (5.6) | ||
| Patel, 2020 [41] | 170 | 30-day | 2 (1.2) | 9 (5.3) | 20 (11.8) | 9 (5.3) | |||
| Huang, 2019 [64] | 31 | 2-year | 3 (10) | 2 (6.7) | 5 (16.7) | 5 (16.7) | 0 | 13 (41.9) | |
| Fraccaro, 2020 [13] | 51 | 30-day | 1 (2) | 2 (3.9) | 2 (3.9) | 17 (33.4) | 8 (15.6) | 6 (11.8) | |
| Jalava, 2019 [65] | 210 | 30-day | 8 (3.8) | 56 (26.8) | 26 (12.3) | 7 (3.3) | 10 (4.8) | ||
| Enta, 2020 [39] | 87 | 76 (87.4) | 30-day | 3 (3.4) | 19 (21.8) | 13 (14.9) | 20 (22.9) | 2 (2.4) | 8 (9.2) |
| Maidman, 2020 [42] | 17 | 30-day | 0 | 0 | 2 (11.7) | ||||
| Bianco, 2021 [40] | 247 | 30-day | 9 (3.6) | 7 (2.8) | 13 (5.2) | 16 (6.5) | |||
| Lux, 2021 [66] | 53 | 1-year | 1 (1.9) | 1 (1.9) | 15 (28.3) | ||||
| Kaewkes, 2021 [67] | 139 | 30-day | 5 (4) | 9 (6) | 8 (5.7) | 5 (4) | 46 (39) | 11 (8) |
PVL: paravalvular leak